ACE-inhibitory effect and physicochemical characteristics of yogurt beverage fortified with whey protein hydrolysates

Korean Journal for Food Science of Animal Resources

Volumn 31, Issue 6, 2011, Pages 886-892

  Lim, Sung Min ^a   Lee, Na Kyoung ^a   Park, Keun Kyu ^a   Yoon, Yoh Chang ^a   Paik, Hyun Dong ^a  

^a Konkuk University   (South Korea)

Author keywords

Angiotensin converting enzyme; Whey protein hydrolysate; Yogurt beverage

Indexed keywords

EID: 84855685332     PISSN: 12258563     EISSN: None     Source Type: Journal    
DOI: 10.5851/kosfa.2011.31.6.886     Document Type: Article

References (29)

1. AOAC (1995) Official methods of analysis. 16th ed, Association of Official Analytical Chemists, Washington, DC, USA.
2. Ariyoshi, Y. (1993) Angiotensin-converting enzyme inhibitor derived from food protein. Trends Food Sci. Technol. 4, 139-144.
3. Campbell, D. J. (2003) The renin-angiotensin and the kallikrein- kinin systems. Int. J. Biochem. Cell Biotechnol. 35, 784-791. (Pubitemid 36379320)
4. Christensen, J. E., Dudley, E. G., Pederson, J. A., and Steele, J. L. (1999) Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76, 217-246. (Pubitemid 29440729)
5. Clare, A. and Swaisgood, H. E. (2000) Bioactive milk peptides: a prospectus. J. Dairy Sci. 86, 1187-1195.
6. Cushman, D. W. and Cheung, H. S. (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637-1648.
7. Donkor, O. N., Henriksson, A., Vasiljevic, T., and Shah, N. P. (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of viability and in vitro angiotensin- converting enzyme inhibitory activity in fermented milk. Lait 87, 21-38. (Pubitemid 46615418)
8. FitzGerald, R. J. and Murray, B. A. (2006) Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59, 118-125.
9. Fuglsang, A., Nilsson, D., and Nyborg, N. C. B. (2002) Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl. Environ. Microbiol. 68, 3566-3569. (Pubitemid 34734060)
10. Fujita, H., Yamagami, T., and Ohshima, K. (2001) Effects of an ACE inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 21, 1149-1158. (Pubitemid 32905727)
11. Jang, A. and Lee, M. (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci. 69, 653-661. (Pubitemid 40119920)
12. Kim, S. B., Seo, I. S., Khan, M. A., Ki, K. S., Nam, M. S., and Kim, H. S. (2007) Separation of iron-binding protein from whey through enzymatic hydrolysis. Int. Dairy J. 17, 625-631. (Pubitemid 46274286)
13. Korhonen, H. J. T. and Pihlanto, A. (2006) Bioactive peptides: Production and functionality. Int. Dairy J. 16, 945-960. (Pubitemid 44255683)
14. Kunji, E. R. S., Mierau, I., Hagting, A., Poolman, B., and Konings, W. N. (1996) The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 70, 187-221. (Pubitemid 26355500)
15. López-Fandino, R., Otte J., and van Camp, J. (2006) Physiological, chemical and technological aspects of milk-proteinderived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16, 1277-1293. (Pubitemid 44331581)
16. Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., and Gobbetti, M. (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 69, 5297-5305. (Pubitemid 37150754)
17. Nicholas, J. A. and Eric, C. R. (1996) Characterization of casein phosphopeptides prepared using alcalase. Enzyme Microb. Technol. 19, 202-207.
18. Otte, J., Qvist, K. B., Pedersen, M., Vogensen, F. K., and Flambard, B. (2003) ACE-inhibitory activity of fermented milks: Effects of culture and protein concentration. Poster at the Conference Milk Proteins: Quality and Health Aspects., Wadahl, Norway, pp. 13-16.
19. Pihlanto-Leppala, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H. (2000) Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67, 53-64. (Pubitemid 30104846)
20. SAS (1999) SAS/STAT Software for PC. SAS Institute Inc., Cary, NC, USA.
21. Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330. (Pubitemid 36133373)
22. Shah, N. P. (2000) Effect of milk-derived bioactives: An overview. Br. J. Nutr. 84, S3-S10.
23. Silvia, S. V. and Malcata, F. X. (2005) Caseins as source of bioactive peptides. Int. Dairy J. 15, 1-15. (Pubitemid 39527112)
24. Sinha, R., Radha, C., Prakash, J., and Kaul, P. (2007) Whey protein hydrolysate: Functional properties, nutritional quality and utilization in beverage formulation. Food Chem. 101, 1484-1491. (Pubitemid 44466234)
25. Van der Ven, C., Grupen, H., Bont, D. B. A., and Voragen, A. G. J. (2002) Optimization of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int. Dairy J. 12, 813-820. (Pubitemid 35180616)
26. Vermeirssen, V., Van Camp, J., Devos, L., and Verstraete, W. (2003) Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: From batch experiment to semicontinuous model. J. Agri. Food Chem. 51, 5680-5687.
27. Yamamoto, N. (1997) Antihypertensive peptides derived from food proteins. Biopolymers 43, 129-134. (Pubitemid 27291391)
28. Yamamoto, N., Akino, A., and Takano, T. (1994) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77, 917-922.
29. Yusuf, S., Lonn, E., Bosch, J., and Gerstein, H. (1999) Summary of randomised trials of angiotensin converting enzyme inhibitors. Clin. Exp. Hypertens. 21, 835-845. (Pubitemid 29325482)